Skip to main content

Table 1 Patient characteristics stratified by circCDYL expression

From: Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression

 

Number of patients

Total

P value

Low circCDYL

High circCDYL

Age

   

0.728

 >35

50

52

102

 

  ≤ 35

6

5

11

 

Menopause

   

0.644

 Yes

35

38

73

 

 No

21

19

40

 

ER status

   

0.035

 Negative

14

25

39

 

 Positive

42

32

74

 

PR status

   

0.106

 Negative

30

39

69

 

 Positive

26

18

44

 

HER2 status

   

0.20

 Negative

38

32

70

 

 Positive

18

25

43

 

Ki67 Level

   

< 0.0001

 Low

48

20

68

 

 High

8

37

45

 

Molecular subtype

   

0.102

 Luminal

42

32

74

 

 HER2+

7

11

18

 

 TNBC

7

14

21

 

Tumor stage

   

0.001

 T1

27

11

38

 

 T2

23

28

51

 

 T3–4

6

18

24

 

Lymphatic stage

   

0.046

 N0

28

17

45

 

 N1

16

17

33

 

 N2–3

12

23

35

 
  1. Abbreviations: ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth receptor 2